{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By DAVID GELLES", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "GELLES"}]}, "abstract": null, "type_of_material": "News", "word_count": "410", "lead_paragraph": "The drug maker increased its bid to $33 billion as it sought to fend off an unsolicited takeover offer from the Israeli pharmaceutical company Teva.", "pub_date": "2015-04-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mylan Raises Its Offer for Perrigo, Which Rejects It", "print_headline": "Mylan Raises Its Offer for Perrigo, Which Rejects It"}, "snippet": "The drug maker increased its bid to $33 billion as it sought to fend off an unsolicited takeover offer from the Israeli pharmaceutical company Teva.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/04/25/business/dealbook/mylan-in-defensive-stance-raises-offer-for-perrigo.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Perrigo Company", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Coury, Robert J", "name": "persons"}], "blog": [], "_id": "553a667238f0d87fad3b3d24", "source": "The New York Times"}